Graves’ Disease Awareness

Dr. Gary Lelli, Vice-Chair of Ophthalmology at Weill Cornell Medicine, discusses the Horizon Therapeutics and Prevent Blindness launch of FOCUS, an initiative created to help those living with Graves’ Disease recognize the symptoms of a separate, but related disease called Thyroid Eye Disease (TED), a serious, progressive and vision-threatening rare autoimmune disease that, in rare cases, can lead to blindness.

Dr. Lelli is Vice Chair of Ophthalmology, a board-certified ophthalmologist who specializes in oculoplastic surgery – a specialty requiring two years of additional training after ophthalmology residency focused solely on plastic and reconstructive surgery of eyelids, orbit, and lacrimal system. During this training, accredited by the prestigious American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Dr. Lelli gained broad clinical and surgical experience while treating patients at Columbia University Medical Center, Manhattan Eye, Ear, and Throat Hospital, New York University Hospital, Bellevue Medical Center and New York Eye and Ear Infirmary.